Smoking Cessation Patch, Gum Prop 65 Warning Federally Preempted - Court
This article was originally published in The Tan Sheet
Executive Summary
Requiring a special California Proposition 65 pregnancy warning on OTC nicotine-containing smoking cessation patches and gums would conflict with FDA requirements, a San Francisco state court judge has ruled.
You may also be interested in...
Kaopectate Prop 65
San Francisco County Judge approves settlement between Pfizer, Attorney General Bill Lockyer in Prop 65 lawsuit regarding Kaopectateanti-diarrheal. Pfizer, which obtained the drug after acquiring Pharmacia, agrees to reformulate Kaopectate liquid with 80% less lead; caplets have not yet been reformulated. "The faster and more extensively Pharmacia removes lead from Kaopectate, the less it will pay in civil penalties," AG's office states June 26. Center for Environmental Health filed suit in 2001 (1"The Tan Sheet" March 26, 2001, p. 21). State AG joined in November 2001...
FDA Prop 65 NRT Warning Rejection Should Be Given Deference, Firms Say
FDA's view that a Prop 65 pregnancy warning on OTC nicotine replacement therapies is "without scientific foundation" should be given more weight, NRT firms assert in a brief filed in California Supreme Court Jan. 21
Prop 65 Smoking Cessation Warnings Not In Conflict With FDA Rules – Court
FDA's newly revised pregnancy warning for OTC smoking cessation products could be expanded to include a statement regarding fetal harm as required under Proposition 65, a San Francisco appellate judge says